Validation of pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma
Validation of pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma
复制标题
DOI:
10.1111/bju.12441
复制
发表时间:
2014-09-01
影响因子:
4.5
通讯作者:
Hutterer, Georg C.
中科院分区:
文献类型:
--
作者:
Dalpiaz, Orietta;Ehrlich, Georg C.;Hutterer, Georg C.
ObjectiveTo investigate the potential prognostic significance of the neutrophil-lymphocyte ratio (NLR) in a large European cohort of patients with upper urinary tract urothelial cell carcinoma (UUT-UCC).Patients and MethodsWe retrospectively evaluated data from 202 consecutive patients with non-metastatic upper urinary tract urothelial cell carcinoma (UUT-UCC), who underwent surgery between 1990 and 2012 at a single tertiary academic centre.Patients' cancer-specific survival (CSS) and overall survival (OS) were assessed using the Kaplan-Meier method.To evaluate the independent prognostic significance of the NLR, multivariate proportional Cox regression models were applied for both endpoints.ResultsA higher NLR was significantly associated with shorter CSS (P = 0.002, log-rank test), as well as with shorter OS (P < 0.001, log-rank test).Multivariate analysis identified a high NLR as an independent prognostic factor for patients' CSS (hazard ratio 2.72, 95% CI 1.25-5.93, P = 0.012), and OS (hazard ratio 2.48, 95% CI 1.31-4.70, P = 0.005).ConclusionsIn the present cohort, patients with a high preoperative NLR had higher cancer-specific and overall mortality after radical surgery for UUT-UCC, compared with those with a low preoperative NLR.This easily identifiable laboratory measure should be considered as an additional prognostic factor in UUT-UCC in future.